Distribution spectrum of paraoxonase activity in HDL fractions

Clinical Chemistry

Volumn 50, Issue 12, 2004, Pages 2309-2315

  Bergmeier, Christoph ^a   Siekmeier, Rüdiger ^b   Gross, Werner ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b BfArM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN A2; APOLIPOPROTEIN E; ARYLDIALKYLPHOSPHATASE; CHOLESTEROL; CLUSTERIN; HIGH DENSITY LIPOPROTEIN;

ADULT; ARTICLE; CHOLESTEROL TRANSPORT; DNA POLYMORPHISM; ENZYME ACTIVITY; FEMALE; HUMAN; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; MALE; NORMAL HUMAN;

ADULT; APOLIPOPROTEIN A-I; APOLIPOPROTEIN A-II; APOLIPOPROTEINS E; ARYLDIALKYLPHOSPHATASE; CLUSTERIN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENOTYPE; GLYCOPROTEINS; HUMANS; LIPOPROTEINS, HDL; MALE; MOLECULAR CHAPERONES; NEPHELOMETRY AND TURBIDIMETRY; POLYMORPHISM, GENETIC; ULTRACENTRIFUGATION;

EID: 9244247649     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2004.034439     Document Type: Article

References (18)

1. La Du BN, Aviram M, Billecke S, Navab M, Primo-Parmo S, Sorenson RC, et al. On the physiological role(s) of the parapxonases. Chem Biol Interact 1999;119-120:379-88.
2. Mackness MI, Mackness B, Durrington PN, Connelly PW, Hegele RA. Paraoxonase: biochemistry, genetics and relationship to plasma lipoproteins [Review]. Curr Opin Lipidol 1996;7:69-76.
3. Humbert R, Adler DA, Disteche CM, Hassett C, Omiecinski CJ, Furlong CE. The molecular basis of the human serum paraoxonase activity polymorphism. Nat Genet 1993;3:73-6.
4. Leviev I, James RW. Promoter polymorphisms of human paraoxonase PON1 gene and serum paraoxonase activities and concentrations. Arterioscler Thromb Vasc Biol 2000;20:516-21.
5. Kitchen BJ, Masters CJ, Winzor DJ. Effects of lipid removal on the molecular size and kinetic properties of bovine plasma arylesterase. Biochem J 1973;135:93-9.
6. Don MM, Masters CJ, Winzor DJ. Further evidence for the concept of bovine plasma arylesterase as a lipoprotein. Biochem J 1975;151:625-30.
7. Graham A, Hassall DG, Rafique S, Owen JS. Evidence for a paraoxonase-independent inhibition of low-density lipoprotein oxidation by high-density lipoprotein. Atherosclerosis 1997;135:193-204.
8. Chemnitius JM, Winkel H, Meyer I, Schirrmacher K, Armstrong VW, Kreuzer H, et al. Age related decrease of high density lipoproteins (HDL) in women after menopause. Quantification of HDL with genetically determined HDL arylesterase in women with healthy coronary vessels and in women with angiographically verified coronary heart disease. MedKlin 1998;93:137-45.
9. 3-arylesterase. Eur Heart J 1994;15(Suppl):612.
10. Alaupovic P, Lee DM, McConathy WJ. Studies on the composition and structure of plasma lipoproteins. Distribution of lipoprotein families in major density classes of normal human plasma lipoproteins. Biochim Biophys Acta 1972;260:689-707.
11. Furlong CE, Richter RJ, Seidel SL, Motulsky AG. Role of genetic polymorphism of human plasma paraoxonase/arylesterase in hydrolysis of the insecticide metabolites chlorpyrifos oxon and paraoxon. Am J Hum Genet 1988;43:230-8.
12. 3 in a high capacity fixed angle Rotor. Arztl Lab 1988;34:265-70.
13. Kostner GM, März W. Zusammensetzung und Stoffwechsel der Lipoproteine. In: Schwandt P, Richter WO, Parhofer KG, eds. Handbuch der Fettstoffwechselstörungen, 2nd ed. Stuttgart: Schattauer, 2001:1-57.
14. März W, Gross W. Immunochemical evidence for the presence in human plasma of lipoproteins with apolipoprotein A-II as the major protein constituent. Biochim Biophys Acta 1988;962:155-8.
15. Brackley M, Carro-Ciampi G. Stability of the paraoxonase phenotyping ratio in collections of human sera with differing storage times. Res Commun Chem Pathol Pharmacol 1983;41:65-78.
16. Forte TM, Oda MN, Knoff L, Frei B, Suh J, Harmony JA, et al. Targeted disruption of the murine lecithin:cholesterol acyltransferase gene is associated with reductions in plasma paraoxonase and platelet-activating factor acetylhydrolase activities but not in apolipoprotein J concentration. J Lipid Res 1999;40:1276-83.
17. Sorenson RC, Aviram M, Bisgaier CL, Billecke S, Hsu C, La Du BN. Properties of the retained N-terminal hydrophobic leader sequence in human serum paraoxonase:arylesterase. Chem Biol Interact 1999;119-120:243-9.
18. Navab M, Hama-Levy S, Van Lenten BJ, Fonarow GC, Cardinez CJ, Castellani LW, et al. Mildly oxidized LDL induces an increased apolipoprotein J/paraoxonase ratio. J Clin Invest 1997;99:2005-19.